Comparison of MOLLI, shMOLLLI, and SASHA in discrimination between health and disease and relationship with histologically derived collagen volume fraction

European Heart Journal Cardiovascular Imaging

Volumn 19, Issue 7, 2018, Pages 768-776

  Child, Nicholas ^a,b   Suna, Gonca ^b,c   Dabir, Darius ^a,d   Yap, May Lin ^a   Rogers, Toby ^a,c   Kathirgamanathan, Misha ^a   Arroyo Ucar, Eduardo ^a,e   Hinojar, Rocio ^a   Mahmoud, Islam ^a   Young, Christopher ^a   Wendler, Olaf ^f   Mayr, Manuel ^b   Sandhu, Banher ^a   Morton, Geraint ^g   Muhly Reinholz, Marion ^h   Dimmeler, Stefanie ^h   Nagel, Eike ^a,i   Puntmann, Valentina O ^a,i  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF BONN   (Germany)

^e HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^f KING S COLLEGE HOSPITAL   (United Kingdom)

^g PORTSMOUTH HOSPITALS NHS TRUST   (United Kingdom)

^h GOETHE UNIVERSITY   (Germany)

ⁱ UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

collagen; MOLLI; SASHA; shMOLLI; T1 mapping

Indexed keywords

C REACTIVE PROTEIN; TROPONIN; CONTRAST MEDIUM;

AORTIC STENOSIS; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BODY MASS; CARDIOVASCULAR FUNCTION; CLINICAL ARTICLE; COLLAGEN VOLUME FRACTION; CONGESTIVE CARDIOMYOPATHY; DIASTOLIC BLOOD PRESSURE; EXTRACELLULAR SPACE; EXTRACELLULAR VOLUME FRACTION; FIBROSING ALVEOLITIS; HEART LEFT VENTRICLE EJECTION TIME; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HEART RATE; HEART RIGHT VENTRICLE EJECTION FRACTION; HISTOLOGY; HUMAN; INFORMATION PROCESSING; INTERMETHOD COMPARISON; MODIFIED LOOK LOCKER INVERSION RECOVERY; NONISCHAEMIC DILATED CARDIOMYOPATHY; NONISCHEMIC CARDIOMYOPATHY; PRIORITY JOURNAL; SATURATION RECOVERY SINGLE SHOT ACQUISITION; SHORTENED MODIFIED LOOK LOCKER INVERSION RECOVERY; ADULT; AGED; BODY SURFACE POTENTIAL MAPPING; CARDIOMYOPATHY; CINE MAGNETIC RESONANCE IMAGING; COHORT ANALYSIS; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; FEMALE; HEART FAILURE; IMAGING PHANTOM; MALE; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; REPRODUCIBILITY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BODY SURFACE POTENTIAL MAPPING; CARDIOMYOPATHIES; COHORT STUDIES; CONTRAST MEDIA; FEMALE; HEART FAILURE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; PHANTOMS, IMAGING; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 85051003325     PISSN: 20472404     EISSN: 20472412     Source Type: Journal    
DOI: 10.1093/ehjci/jex309     Document Type: Article

References (48)

1. Puntmann VO, Peker E, Chandrashekhar Y, Nagel E. T1 mapping in characterizing myocardial disease. Circ Res 2016;119:277-99.
2. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69: 89-95.
3. Higgins DM, Moon JC. Review of T1 mapping methods: Comparative effectiveness including reproducibility issues. Curr Cardiovasc Imaging Rep 2014;7:9252.
4. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP. Modified Look-Locker inversion recovery (MOLLI) for high-resolutionT1 mapping of the heart. Magn Reson Med 2004;52:141-6.
5. Piechnik SK, Ferreira VM, Dall'Armellina E, Cochlin LE, Greiser A, Neubauer S et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson 2010;12:69.
6. Lee JJ, Liu S, Nacif MS, Ugander M, Han J, Kawel N et al. Myocardial T1 and extracellular volume fraction mapping at 3 tesla. J Cardiovasc Magn Reson 2011; 13:75.
7. Radunski UK, Lund GK, Stehning C, Schnackenburg B, Bohnen S, Adam G et al. CMR in patients with severe myocarditis. JACC Cardiovasc Imaging 2014;7:667-75.
8. Chow K, Flewitt JA, Green JD, Pagano JJ, Friedrich MG, Thompson RB. Saturation recovery single-shot acquisition (SASHA) for myocardial T1mapping. Magn Reson Med 2014;71:2082-95.
9. Roujol S, Weingärtner S, Foppa M, Chow K, Kawaji K, Ngo LH et al. Accuracy, precision, and reproducibility of four T1 mapping sequences: A head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE. Radiology 2014;272: 683-9.
10. Puntmann VO, Carr-White G, Jabbour A, Yu C-Y, Gebker R, Kelle S et al. T1-mapping and outcome in nonischemic cardiomyopathy. JACC Cardiovasc Imaging 2016;9:40-50.
11. Natori S, Lai S, Finn JP, Gomes AS, Hundley WG, Jerosch-Herold M et al. Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity. AJR Am J Roentgenol 2006;186:S357-65.
12. Puntmann VO, Voigt T, Chen Z, Mayr M, Karim R, Rhode K et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging 2013;6:475-84.
13. Puntmann VO, Arroyo Ucar E, Hinojar Baydes R, Ngah NB, Kuo YS, Dabir D et al. Aortic stiffness and interstitial myocardial fibrosis by native T1 are independently associated with left ventricular remodeling in patients with dilated cardiomyopathy. Hypertension 2014;64:762-8.
14. Authors/Task Force members, Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H et al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012; 33:2451-96.
15. Rogers T, Dabir D, Mahmoud I, Voigt T, Schaeffter T, Nagel E et al. Standardization of T1 measurements with MOLLI in differentiation between health and disease-the ConSept study. J Cardiovasc Magn Reson 2013;15:78.
16. Dabir D, Child N, Kalra A, Rogers T, Gebker R, Jabbour A et al. Reference values for healthy human myocardium using a T1 mapping methodology: Results from the International T1 multicenter cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 2014;16:34.
17. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E; Society for Cardiovascular Magnetic Resonance. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson 2013;15:91.
18. Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich MG et al. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Post Processing. J Cardiovasc Magn Reson 2013;15:35.
19. Jerosch-Herold M, Sheridan DC, Kushner JD, Nauman D, Burgess D, Dutton D et al. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2008;295:H1234-42.
20. Kellman P, Hansen MS. T1-mapping in the heart: Accuracy and precision. J Cardiovasc Magn Reson 2014;16:2.
21. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: Preliminary validation in humans. Circulation 2010;122: 138-44.
22. Bull S, White SK, Piechnik SK, Flett AS, Ferreira VM, Loudon M et al. Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Heart 2013;99:932-7.
23. Fontana M, White SK, Banypersad SM, Sado DM, Maestrini V, Flett AS et al. Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR. J Cardiovasc Magn Reson 2012;14:88.
24. White SK, Sado DM, Fontana M, Banypersad SM, Maestrini V, Flett AS et al. T1 mapping for myocardial extracellular volume measurement by CMR. JACC Cardiovasc Imaging 2013;6:955-62.
25. de Meester de Ravenstein C, Bouzin C, Lazam S, Boulif J, Amzulescu M, Melchior J et al. Histological validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T. J Cardiovasc Magn Reson 2015;17:1268.
26. Lee S-P, Lee W, Lee JM, Park E-A, Kim H-K, Kim Y-J et al. Assessment of diffuse myocardial fibrosis by using MR imaging in asymptomatic patients with aortic stenosis. Radiology 2015;274:359-69.
27. Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 2008;52:1574-80.
28. Sibley CT, Noureldin RA, Gai N, Nacif MS, Liu S, Turkbey EB et al. T1 mapping in cardiomyopathy at cardiac MR: Comparison with endomyocardial biopsy. Radiology 2012;265:724-32.
29. Mascherbauer J, Marzluf BA, Tufaro C, Pfaffenberger S, Graf A, Wexberg P et al. Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction. Circ Cardiovasc Imaging 2013;6:1056-65.
30. Miller CA, Naish JH, Bishop P, Coutts G, Clark D, Zhao S et al. Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging 2013;6:373-83.
31. Aus Dem Siepen F, Buss SJ, Messroghli D, Andre F, Lossnitzer D, Seitz S et al. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: Quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. Eur Heart J Cardiovasc Imaging 2015;16:210-6.
32. Iles LM, Ellims AH, Llewellyn H, Hare JL, Kaye DM, McLean CA et al. Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis. Eur Heart J Cardiovasc Imaging 2015;16:14-22.
33. Kammerlander AA, Marzluf BA, Zotter-Tufaro C, Aschauer S, Duca F, Bachmann A et al. T1 mapping by CMR imaging. JACC Cardiovasc Imaging 2016;9:14-23.
34. Schelbert EB, Sabbah HN, Butler J, Gheorghiade M. Employing extracellular volume cardiovascular magnetic resonance measures of myocardial fibrosis to foster novel therapeutics. Circ Cardiovasc Imaging 2017;10:e005619.
35. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U et al. The role of endomyocardial biopsy in the management of cardiovascular disease: A scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 2007;116: 2216-33.
36. Chin CWL, Semple S, Malley T, White AC, Mirsadraee S, Weale PJ et al. Optimization and comparison of myocardial T1 techniques at 3T in patients with aortic stenosis. Eur Heart J Cardiovasc Imaging 2014;15:556-65.
37. Child N, Yap ML, Dabir D, Rogers T, Suna G, Sandhu B et al. T1 values by conservative septal postprocessing approach are superior in relating to the interstitial myocardial fibrosis: Findings from patients with severe aortic stenosis. J Cardiovasc Magn Reson 2015;17:P49.
38. Robson MD, Piechnik SK, Tunnicliffe EM, Neubauer S. T1measurements in the human myocardium: The effects of magnetization transfer on the SASHA and MOLLI sequences. Magn Reson Med 2013;70:664-70.
39. Hinojar R, Foote L, Arroyo Ucar E, Jackson T, Jabbour A, Yu C-Y et al. Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis. JACC Cardiovasc Imaging 2015;8:37-46.
40. Lurz P, Luecke C, Eitel I, Föhrenbach F, Frank C, Grothoff M et al. Comprehensive cardiac magnetic resonance imaging in patients with suspected myocarditis. J Am Coll Cardiol 2016;67:1800-11.
41. Fernández-Jiménez R, García-Prieto J, Sánchez-González J, Aguëro J, López-Martín GJ, Galán-Arriola C et al. Pathophysiology underlying the bimodal edema phenomenon after myocardial ischemia/reperfusion. J Am Coll Cardiol 2015;66: 816-28.
42. Ugander M, Bagi PS, Oki AJ, Chen B, Hsu L-Y, Aletras AH et al. Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. JACC Cardiovasc Imaging 2012;5:596-603.
43. Hill JA, Olson EN. Cardiac plasticity. N Engl J Med 2008;358:1370-80.
44. Westermann D, Lindner D, Kasner M, Zietsch C, Savvatis K, Escher F et al. Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ Heart Fail 2011;4: 44-52.
45. van Heerebeek L, Franssen CPM, Hamdani N, Verheugt FWA, Somsen GA, Paulus WJ. Molecular and cellular basis for diastolic dysfunction. Curr Heart Fail Rep 2012;9:293-302.
46. Frey N, Olson EN, Hill JA. Mechanisms of stress-induced cardiac hypertrophy. In: Muscle. Elsevier; 2012. p481-94.
47. Lazzeroni D, Rimoldi O, Camici PG. From left ventricular hypertrophy to dysfunction and failure. Circ J 2016;80:555-64.
48. Dimmeler S, Zeiher AM. Netting insights into fibrosis. N Engl J Med 2017;376: 1475-7.